Abstract The Nrf2/ARE pathway is a major cellular defense mechanism that prevents damage by reactive oxygen species through induction of antioxidative phase II enzymes. However, the activity of the Nrf2/ARE system is not uniform with variability in response presumed to be dependent on the Nrf2 genotype. We recently completed a pilot human coffee intervention trial with healthy humans, where large interindividual differences in the antioxidative response to the study coffee were examined. Here, we address the question whether differences in the modulation of Nrf2 gene transcription, assessed as an induction of Nrf2 gene transcription by Q-PCR, might be correlated with specific Nrf2 genotypes. To date, nine single nucleotide polymorphisms (SNPs) have been identified in the Nrf2 (NFE2L2) gene. Two of these, the -617C/A and -651G/A SNPs are located within the promoter region and have previously been reported to influence the activity of the Nrf2/ARE pathway by reducing Nrf2 transcriptional activity. Sequencing of the critical Nrf2 gene promoter region not only confirmed the existence of these SNPs within the participants of the trial at the expected frequency (33% carrying the -617C/A, 17% the -651G/A and 56% the -653A/G SNP) but also indicated reduced Nrf2 gene transcription associated with a normal diet if the SNPs at position -617, -651 or -653 were present. Of note, the data also indicated the study coffee increased Nrf2 gene transcription even in SNP carriers. This further highlights the relevance of genotype-dependent induction of Nrf2 gene transcription that appears to be largely influenced by dietary factors.
Background
Reactive oxygen species (ROS) produced by xenobiotic compounds of exogenous and endogenous origin, are considered detrimental to mammalian cell integrity and are correlated with the development of life-threatening ailments including cardiovascular disease and cancer. However, during evolution, mammalian cells have developed different defense systems to mitigate or repair ROS-induced cell damage. One pivotal mechanism is the induction of phase II detoxifying enzymes [1, 2] . As a result, a deficiency in phase II enzyme activity is associated with diseases including an enhanced risk of colon cancer [3, 4] .
The presence of an antioxidant response element (ARE/ EpRE), located in the 5 0 -flanking region of important phase II genes such as glutathione S-transferases (GST), c-glutamate cysteine ligase (cGCL), NAD(P)H, quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO1) [5] [6] [7] plays a critical role in the activation and expression of these genes. ARE is activated via binding of the transcription factor nuclear factor-erythroid 2 p45 subunit (NF-E2)-related factor 2 (Nrf2 or NFE2L2) that is sequestered in the cytoplasm in quiescent cells. Activation by ROS or upstream protein kinases leads to the release of Nrf2, its translocation into the nucleus and the activation of AREdependent gene expression [8] [9] [10] [11] [12] [13] . However, the activity of the Nrf2/ARE (EpRE) system differs dramatically amongst humans. Biochemical studies have associated allelic variations in the Nrf2 promoter region with differences in the ability to increase antioxidative phase II gene transcription [14] . To date, nine single nucleotide polymorphisms (SNP) have been identified in the Nrf2 gene [14] [15] [16] . Of special relevance seems to be the -617C/A polymorphism and the -651G/A SNP, which are located in the promoter region of the gene. Both SNPs were found to reduce the transcriptional activity of Nrf2, reflected by attenuated binding of Nrf2 to the ARE (EpRE), resulting in decreased Nrf2-dependent gene transcription. Furthermore, a correlation between individuals carrying the -651G/A genotype and increased incidence of acute lung injury (ALI), a disease related to reduced antioxidative cell defense, has already been demonstrated [14] .
Recently, we demonstrated that four weeks daily consumption of an Arabica based special study coffee brew with a considerable content in chlorogenic acids (580.1 mg/L) combined with an increased N-methylpyridinium (NMP) concentration (71.4 mg/L), thus enriched in various antioxidants potently increased Nrf2 gene transcription in humans [17] . In both this pilot trial, and an earlier coffee intervention trial [18, 19] large differences in the Nrf2 activation ability were detected amongst individuals, which could not be explained by differential general health status nor nutritional behaviour of the participants. It has previously been reported that genetic variations in certain antioxidative genes critically determine their capability to be activated by bioactive food compounds [20] . Here, we investigated whether the interindividual differences in the response to consumption of a study coffee in association with an otherwise normal diet, could be explained by specific Nrf2 genotypes.
Materials and methods

Coffee brew
The study coffee brew consisted of a special roasted and blended Arabica coffee, characterized by a high concentration of both, green and roasted bean constituents, especially chlorogenic acid and NMP. The caffeine level (720 mg/L) was in an average range of conventional coffee brews. The ground coffee was delivered in vacuum packages 29.5 g, each. Immediately before consumption, the coffee brew was freshly prepared by paper filtration in a conventional coffee machine. Each individual consumed 250 mL (three times a day) applying 600 mL water for 29.5 g ground coffee [19] .
Subjects
The test population was comprised of 18 male participants of the pilot coffee intervention trial performed earlier (Fig. 1 ) [19] . Originally, this intervention trial comprised thirty-three probands. The investigation of the Nrf2 genotype of the Fig. 1 Schedule of the human intervention trial. BC blood collection individuals was performed more than one year after the trial with only 18 participants granting permission to be genotyped. Exclusion criteria applied in the original study included smoking, obesity (BMI [ 32), use of medication and chronic disease. All participants had to be regular coffee drinkers (2-6 cups of coffee/day). Participants were asked to maintain their usual dietary habits for the duration of the study, except for the intake of coffee, caffeinated products, dietary supplements and foods rich in polyphenols. All volunteers were informed of the objectives of the study and consent received for their participation. Each participant was asked to apply the OG-500 Oragene Ò DNA sample collection kit for saliva donation. Genomic DNA (gDNA) was purified following the manufacturer's instructions. Briefly, of the total 2 mL Oragene/saliva sample, 1 mL of sample was transferred into a 1.5 mL microcentrifuge tube, 40 lL of Oragene Ò Purifier was added and the solution mixed gently by inversion. The remaining 1 mL was stored for later use. After 10 min incubation on ice the sample was centrifuged for 3 min at 15,0009g (RT). The clear supernatant was transferred into a 15 mL centrifuge tube, 1 mL of 95% ethanol was added and gently mixed by inverting it 10 times. After a further incubation step (10 min, RT) the sample was centrifuged for 2 min at 15,0009g (RT). The supernatant was discarded and the pellet mixed with 500 lL of 70% ethanol. The sample was incubated for 1 min at RT and the ethanol carefully removed without disturbing the pellet. After completely drying the DNA pellet, the pellet was dissolved in 500 lL of distilled water. To fully re-suspend the DNA, a further incubation step for 20 min at 50°C was added. After ethanol precipitation, the final concentration of DNA was quantified using a ND-1000 spectrophotometer (Nanodrop, Delaware).
Sequencing
SNPs rs35652124, rs6706649 and rs6721961
To amplify the 424 bp polymorphic region of the NFE2L2 gene, 80 ng of gDNA was amplified with 4 lL of GoTaq Ò Flexi buffer (Promega), 2.5 mM MgCl 2 , 0.2 mM dNTP, 0.2 lM of each NFE2L2 primer (forward primer 5 0 -GACCACTCTCCGACCTAAAGG-3 0 and reverse primer 5 0 -CGAGATAAAGAGTTGTTTGCGAA-3 0 ) and 0.2 lL GoTaq Ò to a total reaction volume of 20 lL. Amplification was performed on a Veriti TM 96-well Thermal Cycler (Applied Biosystems) with an initial step of 94°C for 10 min, followed by 30 cycles of 94°C for 45 s, 55°C for 45 s and 72°C for 45 s followed by a final extension of 72°C for 7 min. Following amplification, 5 lL of PCR product was electrophoresed on 2% agarose gels stained with ethidium bromide for 30 min at 80 V. PCR products were purified with the ExoSAP-IT Ò PCR cleanup kit (Affymetrix/USB) according to the manufacturer's instructions. Briefly, 5 lL of PCR product, 1 lL of Exo SAP-IT Ò and 4 lL dH 2 O were carefully mixed prior to incubation at 37°C for 15 min, followed by incubations at 80°C for 15 min and 4°C for 3 min. DNA concentration was quantified using a ND-1000 spectrophotometer (Nanodrop, Delaware) and diluted to a concentration of 20 ng/lL DNA. For the sequencing reaction 1 lL of this DNA was added to 5 lL of BigDye Terminator v3 (BDT v3.1, Applied Biosystems), 1.3 lL of each NFE2L2 primer (one forward and one reverse reaction), 3.0 lL of 59 BDT v3.1 Sequencing buffer to a final volume of 20 lL. Amplification cycles were as follows: 96°C for 1 min, followed by 30 cycles of 96°C for 10 s, 50°C for 5 s and 60°C for 4 min followed by 4°C for 5 min, 10°C for 5 min and 4°C for 2 min. The sequencing reaction product was transferred to a 1.5 mL eppendorf tube and ethanol precipitated by adding 2 lL of iced cold 3 M sodium acetate (pH 5.2) and 2 lL of 125 mM EDTA (pH 8.0). After adding the sequencing reaction product the sample was vortexed briefly, centrifuged at 10,000 g for 5 min, followed by addition of 50 lL of 100% ethanol followed by repeated vortexing and re-spinning the samples at 10,000 g for 5 min. Samples were then incubated for 15 min at RT. The product was then precipitated by centrifugation at 10,0009g followed by an incubation at 4°C for 20 min. The supernatant was removed and the pellet rinsed in 70% ethanol, briefly vortexed and centrifuged again at 10,0009g at 4°C for 5 min. The pellet was completely dried using a DNA Speed Vac Ò (Savant) on high drying mode for 5 min. Samples were then resuspended in 15 lL dH 2 O. The purified products were then either stored at -20°C or directly added into a Micro Amp TM optical 96 well reaction plate (Applied Biosystems) to be analyzed on a 3,130 genetic analyzer (Applied Biosystems).
Gene transcription by Q-PCR
At each of the four different blood collection (BC) points, marking the beginning and the end of the three different periods of the intervention trial ( Fig. 1 ) venous blood samples were collected in EDTA-tubes and stored at room temperature until the individual sampling period was completed. Thereafter, isolation of human peripheral blood lymphocytes (PBL), RNA extraction and Q-PCR were performed as previously reported [18] . Total RNA was extracted from isolated PBLs following the manufactures handbook of the RNeasy Ò Mini Kit (QIAGEN, Hilden, Germany). Following this, 2 lg RNA was reverse-transcribed using Oligo-dT primers and the Omniscript Ò Reverse Transcription Kit (QIAGEN, Hilden, Germany). cDNA obtained from the RT reaction (amount corresponding to 2 lg of total RNA) was subjected to Q-PCR using QuantiTect SYBR Ò Green PCR (QIAGEN, Hilden, Germany). The primer assays used for the NF2L2 gene was:
Hs_NFE2L2_1_SG, QT00027384. b-Actin: Hs_ACTB_1_SG, QT00095431 (QIAGEN, Hilden, Germany). Primer concentrations and Q-PCR reaction parameters were according to manufacturer's guidelines in QuantiTect SYBR Ò Green PCR Handbook 11/2005 (QIAGEN, Hilden, Germany). Each sample was determined in duplicate. A -RT control was included for all assays. The fold changes in expression of the target gene relative to the internal control gene (b-actin) was analyzed using Bio-Opticon Software and the C T data was imported into Microsoft Excel 03. Data of all assays was analyzed by the 2 T -DDC method.
Ethics
The study was approved by the ethics committee of the Landesaerztekammer Rheinland-Pfalz, Mainz, Germany (no 837.207.08(6204)) and an amendment, approved in May 2010. Written consent forms were obtained from all subjects.
Results and discussion
In this study, we examined diet-derived effects on the activity of the antioxidative Nrf2/ARE pathway and assessed these by Q-PCR. Nrf2 gene transcription was examined in 18 healthy male participants who followed the human pilot intervention trial [19] . The study design [for details see 19] included an initial four-week ''wash out'' period where no coffee and a polyphenol poor diet were compulsory. This was followed by daily ingestion of 750 mL of the special study coffee, in three servings for four weeks. The coffee intervention period was followed by another four weeks of ''wash out'' (Fig. 1 ). Before and after each phase of the study Nrf2 gene transcript levels in the PBLs of the participants were quantified by Q-PCR. As summarized in Fig. 2 , Nrf2 gene transcription was significantly increased after four weeks of coffee consumption BC3 (Fig. 2) in comparison to the first wash out period (BC2) and to the second wash out period after coffee consumption (BC4) but also slightly up-regulated in comparison to the individual pre-study diet (BC1). Since all participants were regular coffee drinkers, BC1 also reflects the influence of the individual coffee consumption on Nrf2. However, a significant disparity in the response to the study coffee became apparent. While 36% of participants (termed coffee responders, n = 6) displayed a significant C1.5 alteration of Nrf2 transcription after study coffee consumption in comparison to the wash out period, with no change in gene expression compared to their normal prestudy statues, 64% of the participants (n = 12) demonstrated no change in Nrf2 gene transcription during the course of the study (defined as coffee non-responders).
To further analyze the modulation of Nrf2 gene transcription by dietary factors the participants were stratified according to their basal Nrf2 transcriptional status (BC1), which also reflects the influence of the individual coffee which was consumed before the study. As summarized in Fig. 2b , large differences in the basal Nrf2 transcription level were apparent. From these stratified participants, only 23% (n = 4) of the individuals displayed a C1.5 Nrf2 transcription at the BC1 time point. These participants were classified as normal diet responders. Of note, these participants showed a significantly decreased Nrf2 gene transcription after the study coffee consumption (BC3). In contrast, participants with low basal Nrf2 transcription demonstrated an increase in Nrf2 transcription after study coffee consumption (Fig. 2b) . However, the demonstrated large differences in the Nrf2 transcriptional levels during the normal diet could not be sufficiently explained by the individual diet of the participants nor by the presence or absence of coffee, since all participants had to be regular coffee drinkers (2-6 cups/d). This limitation was implemented to avoid differences in the Nrf2 response due to any effects which might be caused by an adaption to coffee. Taken together, this data demonstrates that participants in the study showed a large variability in their Nrf2 response to the study coffee. In addition, no major differences in age, sex, health status, ethnicity or diet were apparent amongst the study participants [19] . Therefore, the variability in response was thought to be associated with the Nrf2 genotype, known to be critical for the transcriptional activity of Nrf2. Furthermore, single nucleotide polymorphisms (SNPs) in the Nrf2 gene, affecting the Nrf2 activity seem to be widespread: the -617C/A genotype is reported to be evident in 20% of the European (Caucasian) population, the -653A/G in 25% and the -651G/A genotype in 10% (table 1) [14] . Thus, such functionally relevant differences in the Nrf2 genotype amongst the study collective might critically influence the individual's response to the study diet.
We therefore investigated whether differences in the Nrf2/ARE-activation potential could be correlated to specific Nrf2 genotypes by determining the frequency of the -617C/A, the -653A/G and the -651G/A genotype in the participants of the trial by sequencing a 424 bp polymorphic region of the NFE2L2 gene (Fig. 3) . As summarized in table 2, the -617C/A SNP was present in 6/18 or 33% of the participants, whereas 56% of the participants demonstrated the SNP at position -653A/G. The -651G/A SNP was only observed in 17% (3/18) of the individuals examined. The frequency of the SNPs found within the study population is in agreement with findings of Marcez et al. [14] who reported -653A/G as the most common genotype and -651G/A as appearing only rarely in Caucasians. Overall, the frequency of the SNPs found in the present study appeared slightly higher than previously published data, but this may be due to the relatively low number of samples examined. When considering the potential correlation of Nrf2 genotypes of the participants with their antioxidative response (Nrf2 gene transcription at BC3 C 1.5), 50% of the -617 WT carriers (participants carrying the wild-type sequence at position -617) showed increased Nrf2 gene transcription (C1.5) after both their normal diet (BC1) and likewise, after four weeks of coffee consumption (BC3) when compared to the wash out period (BC2) (Fig. 4a) . Only 33% of the -617 SNP carriers demonstrated an increased Nrf2 gene transcription on a normal diet. These findings are in line with Marzec et al. [14] who reported an influence of the SNP-617 on Nrf2 gene transcription, resulting in a reduced transcriptional activity of Nrf2. Interestingly, the number of -617 SNP carriers showing an elevated Nrf2 transcription increased by another 50% after coffee consumption, indicating the potential of the study coffee to increase transcription, especially within carriers of this genotype.
We next examined the potential role of the -651C/A SNP on Nrf2 activation after coffee consumption. Of the coffee responders, 83% carried the WT sequence, the same frequency as individuals carrying the WT and showing an increased Nrf2 transcription level upon their individual diet. Although none of the -651 SNP carriers displayed elevated Nrf2 transcription under normal dietary conditions, 17% of these participants responded after coffee consumption with increased Nrf2 transcription. Supporting this data, a reduced Nrf2 transcription activity of -651 SNP has been previously reported [14] . The increase in Nrf2 transcript levels found in the present study, even in individuals carrying the -651C/A SNP after coffee ingestion suggests the study coffee to be an effective Nrf2 activator.
When we correlated the Nrf2 response with the presence of the -653A/G SNP, WT carriers demonstrated increased Nrf2 transcription after coffee consumption (50%). In contrast, of the -653A/G SNP carriers only 12.5% of the responders showed an increased Nrf2 transcription during their normal diet, which increased to 37.5% after study coffee consumption. This is in contrast to Marzec et al. [14] who failed to detect any effect of the -653A/G SNP on increased transcription of Nrf2. We then examined the transcriptional changes of Nrf2 during the course of the trial for participants with Nrf2 gene transcription at base (BC1 C 1.5) and correlated this with genotypes. As shown in Fig. 4b the frequency of -617WT carriers who respond under their normal diet was 75%, whereas only 25% of this group demonstrated any increase in Nrf2 transcription after coffee consumption. Of note, in these participants, the frequency of participants (25%) carrying the -617 SNP and acting as normal diet responders remained the same after coffee consumption. The same trend was apparent for the -651 SNP.
In the group with enhanced Nrf2 transcription [1.5 at base (normal diet responders) the frequency of the -651WT genotype was 100%. Thus, all participants who showed a C1.5 level of Nrf2 transcription at BC1 carried the WT genotype. Interestingly, this was reduced to 50% after the study coffee consumption. The -651 SNP was not observed in normal diet responders at either the BC1 nor BC3 time-points. Taken together, this data seems to indicate, that under normal dietary conditions, -617WT and -651WT carriers have an elevated basal level of Nrf2 transcription, which does not appear to be affected by coffee consumption. Whether WT carriers for these two SNPs need additional dietary or other factors to regulate their Nrf2 transcription levels is as yet unknown. When we examined the -653 SNP in these non-responders (Fig. 4b) , the frequency of -653WT carriers as well as -653 SNP carriers demonstrating a C1.5 increase in gene transcription remained the same with 50% showing an increase after BC1 and 25% following coffee consumption (BC3). As such, no -653 genotype dependent modulation seemed to be associated with this SNP.
The increased sensitivity of SNP carriers to coffee in comparison to WT is also apparent when comparing the magnitude of Nrf2 activation after coffee consumption. As demonstrated in Fig. 4c , WT carriers do not show any increase in Nrf2 gene transcription after coffee consumption (BC3, 0.9 ± 0.2) whereas individuals, carrying at least one SNP display elevated Nrf2 transcript levels at (BC3), with the -617 SNP showing a significant difference to WT carriers (1.6 ± 0.5).
Supported by previous studies, our data indicate the presence of a specific Nrf2 genotype to be relevant for the regulation of antioxidative Nrf2 signalling [14, 16] . Interestingly, individuals carrying SNPs at positions -617, -651 or -653 displayed a reduced Nrf2 transcription at base under normal dietary conditions. However, the study coffee induced increased antioxidative Nrf2 transcription in these individuals. The finding that SNP carriers responded more strongly to the study coffee is further supported by the correlation of Nrf2 genotypes to previously examined changes of oxidation related biochemical parameters (Table 3 ). This relates to reduced spontaneous and oxidative DNA damage after coffee consumption in white blood cells as well as improved plasma glutathione status (GSH) and enhanced glutathione reductase activity [for detail see 19] . Carriers of the -651G/A seem to display enhanced sensitivity to the study coffee as demonstrated by increased Nrf2 transcription, marked reduction in DNA damage, increased plasma GSH levels, which together indicate an enhanced antioxidative cellular response [18, 19] .
A genotype-dependent sensitivity towards various drugs due to a genotype-dependent reduced/increased activity of critical metabolic enzymes, resulting in a changed pattern of metabolites has been widely investigated [20, 21] . Furthermore, individuals, who carry a GSTT1*0 genotype fail to show any cancer-protective effects that have been associated with green tea consumption in other populations, indicating a genotype-dependent response to nutrition [22] . However, to our knowledge an increased onset of, generally less active genotypes due to dietary changes has not been reported so far. The investigated Nrf2 SNPs however, do not result in gene deletion but only reduce the transcriptional activity of the Nrf2 gene [14] . Thus, even in Table 3 Correlation of the Nrf2 genotype to changes in Nrf2 gene transcription, oxidative DNA damage in white blood cells and the modulation of plasma glutathione (GSH) after coffee consumption (BC3) in comparison to the previous wash out period (BC2) [for detail see 19] SNP carriers, a principal activation of Nrf2 should be possible. Taking into account the high antioxidative potential of the respective study coffee, providing a broad spectrum of bioactive constituents [18] , an elevated potential of the coffee to activate Nrf2 gene transcription even in SNP carriers in comparison to the individual nutrition, which depending on the chosen food pattern might even offer only a limited selection of antioxidants, seems to be likely.
Conclusions
Our data indicate individuals carrying SNPs at position -617, -651 or -653 to be less likely to display an increased Nrf2 gene transcription at base, reflecting normal dietary conditions. In these individuals, consumption of a special study coffee resulted in increased Nrf2 gene transcription. In contrast, WT carriers demonstrated a higher level of transcription at base, in a situation where antioxidative food constituents are provided from various sources. To our knowledge, this study is the first to highlight the functional relevance of (a) specific Nrf2 genotypes to the activation of antioxidative Nrf2 gene transcription in healthy individuals and to (b) diet related modulation of Nrf2 gene transcription in individuals. Confirmatory studies with a larger population cohort are now under way to validate these exploratory findings.
